Intellia Therapeutics, Inc.
NTLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $193 | $156 | $127 | $189 |
| Short-Term Investments | $318 | $303 | $377 | $412 |
| Receivables | $11 | $11 | $11 | $9 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $60 | $25 | $37 | $30 |
| Total Curr. Assets | $582 | $496 | $551 | $640 |
| Property Plant & Equip (Net) | $138 | $189 | $190 | $247 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $188 | $197 | $228 | $304 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $17 | $17 | $17 | $0 |
| Total NC Assets | $343 | $403 | $435 | $551 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $925 | $899 | $986 | $1,191 |
| Liabilities | – | – | – | – |
| Payables | $13 | $10 | $12 | $15 |
| Short-Term Debt | $27 | $27 | $39 | $20 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $17 | $21 | $21 |
| Other Curr. Liab. | $53 | $42 | $41 | $55 |
| Total Curr. Liab. | $94 | $95 | $113 | $111 |
| LT Debt | $71 | $76 | $80 | $190 |
| Deferred Rev, NC | $0 | $13 | $13 | $18 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $0 | $0 | $0 |
| Total NC Liab. | $83 | $88 | $94 | $208 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $98 | $103 | $119 | $210 |
| Total Liabilities | $177 | $184 | $206 | $319 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,494 | -$2,393 | -$2,292 | -$2,177 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $3,242 | $3,108 | $3,071 | $3,049 |
| Total Equity | $748 | $715 | $780 | $872 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $925 | $899 | $986 | $1,191 |
| Net Debt | -$95 | -$54 | -$8 | $21 |